Longitudinal assessment of synovial, lymph node, and bone volumes in inflammatory arthritis in mice by in vivo magnetic resonance imaging and microfocal computed tomography
Open Access
- 29 November 2007
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 56 (12) , 4024-4037
- https://doi.org/10.1002/art.23128
Abstract
Objective To develop longitudinal 3‐dimensional (3‐D) measures of outcomes of inflammation and bone erosion in murine arthritis using contrast‐enhanced magnetic resonance imaging (CE‐MRI) and in vivo microfocal computed tomography (micro‐CT) and, in a pilot study, to determine the value of entry criteria based on age versus synovial volume in therapeutic intervention studies. Methods CE‐MRI and in vivo micro‐CT were performed on tumor necrosis factor–transgenic (TNF‐Tg) mice and their wild‐type littermates to quantify the synovial and popliteal lymph node volumes and the patella and talus bone volumes, respectively, which were validated histologically. These longitudinal outcome measures were used to assess the natural history of erosive inflammatory arthritis. We also performed anti‐TNF versus placebo efficacy studies in TNF‐Tg mice in which treatment was initiated according to either age (4–5 months) or synovial volume (3 mm3 as detected by CE‐MRI). Linear regression was performed to analyze the correlation between synovitis and focal erosion. Results CE‐MRI demonstrated the highly variable nature of TNF‐induced joint inflammation. Initiation of treatment by synovial volume produced significantly larger treatment effects on the synovial volume (P = 0.04) and the lymph node volume (P < 0.01) than did initiation by age. By correlating the MRI and micro‐CT data, we were able to demonstrate a significant relationship between changes in synovial and patellar volumes (R2 = 0.75, P < 0.01). Conclusion In vivo CE‐MRI and micro‐CT 3‐D outcome measures are powerful tools that accurately demonstrate the progression of erosive inflammatory arthritis in mice. These methods can be used to identify mice with arthritis of similar severity before intervention studies are initiated, thus minimizing heterogeneity in outcome studies of chronic arthritis seen between genetically identical littermates.Keywords
This publication has 46 references indexed in Scilit:
- Magnetic resonance imaging in patients with rheumatoid arthritis with complete remission treated with disease-modifying antirheumatic drugs or anti-tumour necrosis factor α agentsAnnals of the Rheumatic Diseases, 2007
- Infliximab improves productivity and reduces workday loss in patients with ankylosing spondylitis: Results from a randomized, placebo‐controlled trialArthritis Care & Research, 2006
- Reliability and sensitivity to change of the OMERACT rheumatoid arthritis magnetic resonance imaging score in a multireader, longitudinal settingArthritis & Rheumatism, 2005
- Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor–mediated arthritisArthritis & Rheumatism, 2004
- MRI of the wrist in early rheumatoid arthritis can be used to predict functional outcome at 6 yearsAnnals of the Rheumatic Diseases, 2004
- Molecular imaging in living subjects: seeing fundamental biological processes in a new lightGenes & Development, 2003
- Tumor necrosis factor α‐mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerinArthritis & Rheumatism, 2002
- Magnetic resonance imaging‐determined synovial membrane and joint effusion volumes in rheumatoid arthritis and osteoarthritis. Comparison with the macroscopic and microscopic appearance of the synoviumArthritis & Rheumatism, 1997
- Measurement of synovial lining volume by magnetic resonance imaging of the knee in chronic synovitisAnnals of the Rheumatic Diseases, 1997
- Magnetic Resonance Imaging, Histology, and X-Ray of Three Stages of Damage to the Knees of STR/ORT MiceInvestigative Radiology, 1996